Results 141 to 150 of about 2,919 (202)

Adoption of Closed-System Drug Transfer Devices: Effectiveness in Reducing Occupational Exposure to Hazardous Drugs and the Change Management Process. [PDF]

Can J Hosp Pharm
Hon CY, Ellis J, En Chiang TI, Jeronimo M, Ciconte R, Ménard AD.   +5 more
europepmc   +1 more source

Cyberattaques contre les systèmes d’information de santé au Canada. [PDF]

CMAJ
Harish V, Ackery A, Grant K, Jamieson T, Mehta S.   +4 more
europepmc   +1 more source

[HIV-pulmonary tuberculosis co-infection at the university clinics of Lubumbashi: epidemiological and clinical aspects]. [PDF]

Pan Afr Med J
Tshibang PM, Numbi GY, Bukasa ET, Tshibind EY, Kimbungu TK, Muleka SN.   +5 more
europepmc   +1 more source

EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer. [PDF]

EMBO Mol Med
Tessier CE, Derrien J, Dupuy AMM, Pelé T, Moquet M, Roul J, Douillard E, El Harrif C, Pinson X, Le Gallo M, Godey F, Tas P, Viel R, Grasset E, Prigent C, Letouzé É, Suzanne P, Dallemagne P, Campone M, Weinberg RA, Lees JA, Juin PP, Guen VJ.   +22 more
europepmc   +1 more source

Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs. [PDF]

Cancer Res
Lumeau A, Bery N, Francès A, Gayral M, Labrousse G, Ribeyre C, Lopez C, Nevot A, El Kaoutari A, Hanoun N, Sarot E, Perrier M, Pont F, Cerapio JP, Fournié JJ, Lopez F, Madrid-Mencia M, Pancaldi V, Pillaire MJ, Bergoglio V, Torrisani J, Dusetti N, Hoffmann JS, Buscail L, Lutzmann M, Cordelier P.   +25 more
europepmc   +1 more source